Zhang et al., 2021 - Google Patents
Patch grafting, strategies for transplantation of organoids into solid organs such as liverZhang et al., 2021
View PDF- Document ID
- 15156444144475194100
- Author
- Zhang W
- Lanzoni G
- Hani H
- Overi D
- Cardinale V
- Simpson S
- Pitman W
- Allen A
- Yi X
- Wang X
- Gerber D
- Prestwich G
- Lozoya O
- Gaudio E
- Alvaro D
- Tokaz D
- Dominguez-Bendala J
- Adin C
- Piedrahita J
- Mathews K
- Sethupathy P
- Carpino G
- He Z
- Wauthier E
- Reid L
- Publication year
- Publication venue
- Biomaterials
External Links
Snippet
Epithelial cell therapies have been at an impasse because of inefficient methods of transplantation to solid organs. Patch grafting strategies were established enabling transplantation of≥ 10 7th organoids/patch of porcine GFP+ biliary tree stem/progenitors …
- 210000004185 Liver 0 title abstract description 109
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Patch grafting, strategies for transplantation of organoids into solid organs such as liver | |
| Nicolas et al. | Concise review: liver regenerative medicine: from hepatocyte transplantation to bioartificial livers and bioengineered grafts | |
| Willemse et al. | From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix | |
| Mirmalek-Sani et al. | Immunogenicity of decellularized porcine liver for bioengineered hepatic tissue | |
| Jiang et al. | Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering | |
| Haridass et al. | Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice | |
| Van Meter Jr et al. | Myoblast transplantation in the porcine model: a potential technique for myocardial repair | |
| Cortesini | Stem cells, tissue engineering and organogenesis in transplantation | |
| JP2024161469A (en) | Patch graft composition for cell engraftment | |
| Ogoke et al. | Bioengineering considerations in liver regenerative medicine | |
| Yagi et al. | Whole-organ re-engineering: a regenerative medicine approach in digestive surgery for organ replacement | |
| Booth et al. | Liver bioengineering: current status and future perspectives | |
| Shahraki et al. | Decellularization with triton X-100 provides a suitable model for human kidney bioengineering using human mesenchymal stem cells | |
| Bannasch et al. | Cultured keratinocytes in fibrin with decellularised dermis close porcine full-thickness wounds in a single step | |
| Bartlett et al. | Hepatocyte cell therapy in liver disease | |
| Adil et al. | Recellularization of bioengineered scaffolds for vascular composite allotransplantation | |
| Francipane et al. | The lymph node as a new site for kidney organogenesis | |
| Sehic et al. | Progress in preclinical research on uterus bioengineering that utilizes scaffolds derived from decellularized uterine tissue | |
| Ferrer et al. | New tools in experimental cellular therapy for the treatment of liver diseases | |
| Demko et al. | Perfusion-based recellularization of rat livers with islets of langerhans | |
| Favaron et al. | Establishment of 3-dimensional scaffolds from hemochorial placentas | |
| Davis et al. | The role of stem cells for reconstructing the lower urinary tracts | |
| Gao et al. | Kidney ECM pregel nanoarchitectonics for microarrays to accelerate harvesting gene-edited porcine primary monoclonal spheres | |
| Zivari‐Ghader et al. | Recent scaffold‐based tissue engineering approaches in premature ovarian failure treatment | |
| Guo et al. | Decellularized extracellular matrix for organoid and engineered organ culture |